Metraipolis › archive › dc_43da90d3c865
Cardiotoxicity in low-to-moderate cardiovascular risk patients undergoing anti-HER2 therapy: a prospective cardiac magnetic resonance study — Europe PMC PMID:41140069
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41140069
- DOI
- 10.2478/raon-2025-0043
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T01:20:24.179Z
- SHA-256 of the archived text
3da43326b61f371e27bdbbd4a2c17786168fbbb52027e61bd4b732de91a4ff4e- Stable URL of this page
https://metraipolis.com/documento/dc_43da90d3c865
How to cite
Cardiotoxicity in low-to-moderate cardiovascular risk patients undergoing anti-HER2 therapy: a prospective cardiac magnetic resonance study — Europe PMC PMID:41140069 — Europe PMC (en), https://europepmc.org/article/MED/41140069 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_43da90d3c865 (Metraipolis archive dc_43da90d3c865, sha256 3da43326b61f371e27bdbbd4a2c17786168fbbb52027e61bd4b732de91a4ff4e)
BibTeX
@misc{dc43da90d3c865,
title = {Cardiotoxicity in low-to-moderate cardiovascular risk patients undergoing anti-HER2 therapy: a prospective cardiac magnetic resonance study — Europe PMC PMID:41140069},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41140069},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_43da90d3c865; sha256 3da43326b61f371e27bdbbd4a2c17786168fbbb52027e61bd4b732de91a4ff4e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41140069. Agents can read the archived copy with the MCP tool read_document.